This page is for information related to Flavopiridol and Doxorubicin, one of the combination trials under Clinical Trial Drugs. Feel free to add your own experiences with the trial in the comments section or any other links to useful resources.
[edit] Basic Information
Molecular Targets: cyclin-dependent kinases, src, survivin (for flavopiridol)
Trial: Phase I trial of this drug combination is currently underway - follow this link
GIST Support International website page: link here
[edit] Comments from Trial Participants
[edit] Dave B
Dave was in the Nilotinib trial prior to entering this trial
August 25, 2007
I'm starting a stage 1 clinical trial of Doxyrubicin & Flavopiridol at Sloan-Kettering Thursday.
I don't know anything about exon numbers.
Good luck, Dave
Dave never entered this trial - entered Sorafenib trial instead- see Sorafenib page